Claret Bioscience LLC

Worcester, MA Part of Edenroc Sciences, LLC

UEI
NBKDPRMF8Y27
CAGE
7XJ80
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Limited Liability Company
Entity structure
Partnership or Limited Liability Partnership
NAICS codes registered in SAM.gov
Corporate family
SAM.gov registration date
Physical address
100 Barber Ave, Worcester, MA 01606, USA
Website
claretbio.com
Founded
2017
Employees
11-50
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Claret Bioscience LLC's 5 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
A rapid method for global and targeted mirna next generation sequencing - project summary micrornas (mirnas) are small… Grant · R43HG013444 National Human Genome Research Institute $717,158
DNA extraction supplies for barcode of life Contract · 33315223P00484696 Smithsonian Institution $4,917
A single-strand ligation approach for concomitant DNA and RNA next-generation sequencing from low abundance inputs -… Grant · R43HG011877 National Human Genome Research Institute $673,188
A fast, scalable, cost-effective, single-stranded library protocol for cell-free DNA Grant · R43CA239933 National Cancer Institute $299,918
Exploiting signals of cell-free DNA degradation for clinical research and cancer diagnostics Grant · R43CA232935 National Cancer Institute $298,559

About Claret Bioscience LLC

Written by GovTribe AI ·

Claret Bioscience LLC is a for-profit limited liability company that specializes in developing innovative genomic and transcriptomic technologies for next-generation sequencing (NGS) applications. Registered to receive federal awards since June 2017, the company has secured both federal contracts and grants to support its research and development efforts. Claret Bioscience focuses on creating advanced molecular biology techniques that enhance the efficiency and sensitivity of DNA and RNA sequencing, particularly for challenging sample types such as cell-free nucleic acids and small RNA species.

In terms of federal contracts, Claret Bioscience has provided DNA extraction supplies for the Barcode of Life project. The company received a purchase order contract from the Smithsonian Institution, a civilian agency, in December 2022. This contract, valued at $4,917.00, was for the supply of specialized materials used in DNA extraction processes, which are crucial for genetic barcoding initiatives. The contract was not designated as a set-aside, indicating it was open to general competition. This award demonstrates Claret Bioscience's capability to provide high-quality reagents and supplies for genomic research applications to federal institutions.

Claret Bioscience has been particularly active in securing federal grants to support its research and development efforts in advanced sequencing technologies. The company has received multiple project grants from the National Institutes of Health, specifically from the National Human Genome Research Institute (NHGRI) and the National Cancer Institute (NCI). These grants have funded the development of novel NGS library preparation methods for various applications. A recent grant from NHGRI, awarded in February 2024, supports the development of a rapid miRNA profiling methodology called "miREALLY" for improved cancer diagnosis and monitoring. Another NHGRI grant from September 2021 funded the creation of a single-strand ligation approach for simultaneous DNA and RNA sequencing from low-abundance inputs, aimed at enhancing liquid biopsy-based diagnostics. Additionally, an earlier grant from the NCI in 2019 supported the development of a fast, scalable, and cost-effective single-stranded library protocol for cell-free DNA analysis. These grants highlight Claret Bioscience's focus on advancing NGS technologies for various biomedical applications, particularly in the areas of cancer research and precision medicine.

Quick answers

What is Claret Bioscience LLC's UEI?

Claret Bioscience LLC's Unique Entity ID (UEI) in SAM.gov is NBKDPRMF8Y27.

What is Claret Bioscience LLC's CAGE code?

Claret Bioscience LLC's CAGE code is 7XJ80.

What is Claret Bioscience LLC's primary NAICS code?

Claret Bioscience LLC's primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Where is Claret Bioscience LLC located?

Claret Bioscience LLC's physical address in SAM.gov is 100 Barber Ave, Worcester, MA 01606, USA.

Is Claret Bioscience LLC registered in SAM.gov?

Yes. Claret Bioscience LLC's SAM.gov registration is active through August 13, 2027.

Who is Claret Bioscience LLC's parent company?

Claret Bioscience LLC is part of Edenroc Sciences, LLC.

What is Claret Bioscience LLC's most recent federal award?

Claret Bioscience LLC's most recent federal grant award is A rapid method for global and targeted mirna next generation sequencing - project summary micrornas (mirnas) are small… (R43HG013444), from National Human Genome Research Institute, on February 15, 2024.

On GovTribe

See Claret Bioscience LLC's full federal record

  • Federal contract awards
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login